MARTEK BIOSCIENCES CORP Operating Income
MARTEK BIOSCIENCES CORP reported Operating Income of $50.85 million for the 12-month period ending 2010-10-31, per its 10-K filed 2010-12-29.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2010-12-29
- MARTEK BIOSCIENCES CORP operating income (loss) for the quarter ending 2010-10-31 was -$8.09M, a 146.96% decline year-over-year.
- MARTEK BIOSCIENCES CORP operating income (loss) for the quarter ending 2010-07-31 was $21.14M, a 48.69% increase year-over-year.
- MARTEK BIOSCIENCES CORP operating income (loss) for the quarter ending 2009-10-31 was $17.23M.
- MARTEK BIOSCIENCES CORP operating income (loss) for the quarter ending 2009-07-31 was $14.22M.
- MARTEK BIOSCIENCES CORP operating income (loss) for fiscal 2010 was $50.85M, a 20.07% decline from fiscal 2009.
- MARTEK BIOSCIENCES CORP operating income (loss) for fiscal 2009 was $63.62M, a 13.23% increase from fiscal 2008.
- MARTEK BIOSCIENCES CORP operating income (loss) for fiscal 2008 was $56.18M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2010-10-31 | -$8.09M derived: 10-K 12 month − 10-Q 9 month · filed 2010-12-29 | $13.05M derived: sum of 2 quarters · filed 2010-12-29 | $50.85M 10-K · filed 2010-12-29 | |
| 2010-07-31 | $21.14M 10-Q · filed 2010-09-08 | $58.94M 10-Q · filed 2010-09-08 | ||
| 2009-10-31 | $17.23M derived: 10-K 12 month − 10-Q 9 month · filed 2010-12-29 | $31.45M derived: sum of 2 quarters · filed 2010-12-29 | $63.62M 10-K · filed 2010-12-29 | |
| 2009-07-31 | $14.22M 10-Q · filed 2010-09-08 | $46.38M 10-Q · filed 2010-09-08 | ||
| 2008-10-31 | $56.18M 10-K · filed 2010-12-29 |